You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non-vasospastic subjects

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pain Management Trial in Houston (BreEStim 120, BreEStim 240)

Recruiting
  • Pain Management
  • BreEStim 120
  • BreEStim 240
  • Houston, Texas
    The University of Texas Health Science Center
Apr 23, 2022

Cannabis Dependence Trial in New Haven (PF-04457845, Placebo)

Completed
  • Cannabis Dependence
  • New Haven, Connecticut
    Yale University School of Medicine
Feb 9, 2022

NSCLC Trial in Xiamen (Icotinib, Befotertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Xiamen, Fujian, China
    Feng Ye
Sep 17, 2021

Validate an Early Warning Algorithm for Worsening Heart Failure

Unknown status
  • Chronic Heart Failure
  • Machine-learning Algorithm
  • (no location specified)
Feb 12, 2021

Alcohol Use Disorder Trial in Spokane (Phosphatidylethanol-based Contingency Management, Non-Contingent Control)

Active, not recruiting
  • Alcohol Use Disorder
  • Phosphatidylethanol-based Contingency Management
  • Non-Contingent Control
  • Spokane, Washington
    Catholic Charities of Eastern Washington
May 23, 2022

Effectiveness in Cystic Fibrosis

Active, not recruiting
  • Cystic Fibrosis
  • Contraception
    • Birmingham, Alabama
    • +9 more
    May 11, 2022

    Metastatic Hormone Sensitive Prostate Cancer Trial in China (Enzalutamide, Placebo, Androgen deprivation therapy (ADT))

    Active, not recruiting
    • Metastatic Hormone Sensitive Prostate Cancer
    • Beijing, China
    • +29 more
    Jan 7, 2023

    COVID-19, Influenza A, Influenza Type B Trial in Pelham, Brooklyn (Panbio™ COVID-19/Flu A&B Panel)

    Recruiting
    • COVID-19
    • +2 more
    • Panbio™ COVID-19/Flu A&B Panel
    • Pelham, Alabama
    • +1 more
    Nov 10, 2023

    NSCLC Trial in Ghent (Dendritic cell immunotherapy, Antigen-specific DTH, Control DTH)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Dendritic cell immunotherapy
    • +2 more
    • Ghent, Belgium
      Ghent University Hospital
    Dec 23, 2022

    Social Anxiety Disorder Trial in Los Angeles, Oceanside, Torrance (Low dose RLS103, High dose RLS103, inhaled dry powder)

    Recruiting
    • Social Anxiety Disorder
    • Low dose RLS103
    • +2 more
    • Los Angeles, California
    • +1 more
    Jun 22, 2022

    Chronic Hepatitis b Trial in Guangzhou (LP-128 capsules, Matching Placebo)

    Recruiting
    • Chronic Hepatitis b
    • LP-128 capsules
    • Matching Placebo
    • Guangzhou, Guangdong, China
      NanFang Hospital of Southern Medical University
    Aug 2, 2022

    Healthy Trial in Shanghai (SR419 capsules, Placebo)

    Completed
    • Healthy
    • SR419 capsules
    • Placebo
    • Shanghai, China
      Shanghai Clinical Research Center Phase I Clinical Research Unit
    Aug 2, 2022

    Thoracic Aortic Aneurysm Trial in Santiago (Implant Thoracic Stent Graft)

    Completed
    • Thoracic Aortic Aneurysm
    • Implant Thoracic Stent Graft
    • Santiago, Chile
      Pontificia Universidad Caolica de Chile
    Mar 4, 2021

    Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Trial in Kissimmee, Kansas City, Chesterfield (Inhaled Treprostinil,

    Enrolling by invitation
    • Idiopathic Pulmonary Fibrosis
    • Interstitial Lung Disease
    • Inhaled Treprostinil
    • Treprostinil Ultrasonic Nebulizer
    • Kissimmee, Florida
    • +2 more
    Jul 19, 2022

    Tricuspid Valve Regurgitation Trial in H_olon (Mistral Procedure)

    Recruiting
    • Tricuspid Valve Regurgitation
    • Mistral Procedure
    • H̱olon, Israel
      Wolfson Medical Center
    Mar 14, 2023

    Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Apatinib Mesylate Tablets, Tegafur Gimeracil Oteracil Potassium

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • Apatinib Mesylate Tablets
    • Tegafur Gimeracil Oteracil Potassium Capsules
    • Shanghai, Shanghai, China
      Shanghai ninth people's hospital
    Jul 20, 2022

    Advanced Stage NSCLC Trial in Amsterdam ([18F]F-AraG PET scan)

    Recruiting
    • Advanced Stage Non-small Cell Lung Cancer
    • [18F]F-AraG PET scan
    • Amsterdam, Netherlands
      Amsterdam UMC, location VU University Medical Center
    Jan 17, 2023

    B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • Chronic Lymphocytic Leukemia
    • Cyclophosphamide injection
    • +2 more
    • Charleston, South Carolina
      Hollings Cancer Center at Medical University of South Carolina
    Jan 18, 2023

    T-Prolymphocytic Leukemia Trial in Duarte, Columbus, Houston (APG-115, APG-2575)

    Recruiting
    • T-Prolymphocytic Leukemia
    • Duarte, California
    • +2 more
    Jul 8, 2022

    Perihilar Cholangiocarcinoma Trial in Padova (Liver transplantation)

    Not yet recruiting
    • Perihilar Cholangiocarcinoma
    • Liver transplantation
    • Padova, Italy
      Azienda Ospedale Università di Padova
    Nov 5, 2023

    Tinea Pedis Trial in Portland, Spokane (DBI-001 Gel, DBI-002 Gel, Aqueous Gel)

    Recruiting
    • Tinea Pedis
    • DBI-001 Gel
    • +2 more
    • Portland, Oregon
    • +1 more
    Aug 5, 2022

    NSCLC Trial in Amsterdam (Ipilimumab, Cemiplimab, SBRT)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Amsterdam, Noord-Holland, Netherlands
      Antoni van Leeuwenhoek - Netherlands Cancer Institute
    Jan 10, 2023

    Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)

    Not yet recruiting
    • Neuroendocrine Tumors
    • +6 more
    • Vancouver, British Columbia, Canada
      BC Cancer
    Aug 19, 2022

    Type 2 Diabetes Trial in Beijing (HR17031 injection, INS068 injection, SHR20004 injection)

    Recruiting
    • Type 2 Diabetes
    • HR17031 injection
    • +2 more
    • Beijing, Beijing, China
      Peking university People's Hospital
    Jul 25, 2022

    Glaucoma Trial in United States (Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%)

    Active, not recruiting
    • Glaucoma
    • Rocklatan® (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%
    • Mission Hills, California
    • +20 more
    Jan 6, 2023